A Research Study to Explore the Impact of GP Support Via Text Messages to Patients With Asthma and/or COPD
NCT ID: NCT06419400
Last Updated: 2024-05-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
6053 participants
INTERVENTIONAL
2022-04-01
2023-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mobile Phone Based Structured Intervention
NCT00512837
Intervention to Improve Inhalative Adherence
NCT02386722
Description of the Ability to Learn How to Handle Inhaler Devices in Asthma
NCT03175926
Mobile Phone Text for Optimizing Asthma Treatment
NCT00917410
Efficacy of Mobile Phone Short Message Service (SMS) Reminder and Consultation on Asthma Control
NCT02189616
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This is a behavioural intervention. The intervention will consist of a series of supportive text messages to patients from their GP practice over a 6 month period. The messages will vary in frequency from 2 or 3 in the first weeks of the trial to only 1 or 2 a month in the final months of the trial. The content of the messages will vary; some will contain information about how to use a preventer inhaler, some will emphasise the importance of using it, and some will provide simple reminders to patients to take their inhaler.
All participants will continue to receive their usual care throughout the duration of the study; the text message intervention with be in addition to their usual care.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Supportive Text Messagses
The intervention group will receive a series of supportive text messages over the 6 month trial period, varying in content and frequency. They will also be asked to provide self reported data on their symptoms and their adherence at 3 points in time (start, mid-point, and end of trial).
Supportive text messages
The intervention group will receive a series of supportive text messages over the 6 month trial period, varying in content and frequency.
Control Group
The control group will receive no supportive text messages over the period of the trial. They will be asked to only provide self reported data on their symptoms and their adherence at 3 points in time (start, mid-point, and end of trial).
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Supportive text messages
The intervention group will receive a series of supportive text messages over the 6 month trial period, varying in content and frequency.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Male and females age 18 or older
3. Confirmed diagnosis of asthma and/or COPD as recorded in the patient's GP medical record
4. Currently prescribed a preventer inhaler
5. Access to a mobile phone
6. Ability to check text messages on phone
7. Ability to read
Exclusion Criteria
2. Inability or reluctance to provide responses to the study questionnaires
3. Inability to receive and respond to text messages
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lindus Health
INDUSTRY
Accurx
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Luke Twelves
Role: PRINCIPAL_INVESTIGATOR
Lindus Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Medical Centre
Canterbury, Kent, United Kingdom
Gravesend Medical Centre
Gravesend, Kent, United Kingdom
Jubilee Medical Centre
Longfield, Kent, United Kingdom
Marlowe Park Medical Centre
Rochester, Kent, United Kingdom
High Oak Surgery
Dudley, West Midlands, United Kingdom
Lion Health
Stourbridge, West Midlands, United Kingdom
Wordsley Green Health Centre
Worsley, West Midlands, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Accurx-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.